BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 27384994)

  • 1. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.
    Szász AM; Lánczky A; Nagy Á; Förster S; Hark K; Green JE; Boussioutas A; Busuttil R; Szabó A; Győrffy B
    Oncotarget; 2016 Aug; 7(31):49322-49333. PubMed ID: 27384994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
    Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
    Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
    Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
    Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
    Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
    APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.
    Van Cutsem E; de Haas S; Kang YK; Ohtsu A; Tebbutt NC; Ming Xu J; Peng Yong W; Langer B; Delmar P; Scherer SJ; Shah MA
    J Clin Oncol; 2012 Jun; 30(17):2119-27. PubMed ID: 22565005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
    Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
    ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
    Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX
    Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
    Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
    Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
    Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
    World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Niwa H; Tsuneyama K; Takano Y
    Anticancer Res; 2006; 26(5A):3579-83. PubMed ID: 17094486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer.
    Liu N; Zhou N; Chai N; Liu X; Jiang H; Wu Q; Li Q
    BMC Cancer; 2016 May; 16():321. PubMed ID: 27198692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
    Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
    Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
    Winther M; Alsner J; Tramm T; Nordsmark M
    Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.
    Győrffy B; Surowiak P; Budczies J; Lánczky A
    PLoS One; 2013; 8(12):e82241. PubMed ID: 24367507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
    Yao JC; Wang L; Wei D; Gong W; Hassan M; Wu TT; Mansfield P; Ajani J; Xie K
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4109-17. PubMed ID: 15217947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.
    Peña C; Lathia C; Shan M; Escudier B; Bukowski RM
    Clin Cancer Res; 2010 Oct; 16(19):4853-63. PubMed ID: 20651059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
    Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
    Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.